Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cellsGiuseppa Augello, Melchiorre Cervello|Cell Death and Disease|2018Cited by 47
New Insights into the Behavior of NHC-Gold Complexes in Cancer CellsGiuseppa Augello, Diego Tesauro|Pharmaceutics|2023Cited by 27